ErbB receptor tyrosine kinases contribute to proliferation of malignant melanoma cells: inhibition by gefitinib (ZD1839)
Keyword(s):
Keyword(s):
Keyword(s):
2001 ◽
Vol 13
(2)
◽
pp. 125-130
◽
1999 ◽
Vol 45
(3)
◽
pp. 161-162
Keyword(s):
Keyword(s):